KIORA PHARMACEUTICALS, INC. Deferred Revenue
KIORA PHARMACEUTICALS, INC. (KPRX) had Deferred Revenue of $0 as of 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2019-08-08
- 2019-03-31: Deferred Revenue, Current $0.00.
- 2018-12-31: Deferred Revenue, Current $2.69M.
- 2018-09-30: Deferred Revenue, Current $2.69M.
- 2018-06-30: Deferred Revenue, Current $2.72M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 |
| 2018-12-31 | $2.69M 10-Q · filed 2019-08-08 |
| 2018-09-30 | $2.69M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $2.72M 10-Q · filed 2018-08-03 |
| 2018-03-31 | $2.86M 10-Q · filed 2018-05-11 |
| 2017-12-31 | $12.31M 10-K · filed 2019-03-01 |
| 2017-09-30 | $10.25M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $8.86M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $8.22M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $4.22M 10-K · filed 2018-03-02 |
| 2016-09-30 | $3.42M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $2.56M 10-Q · filed 2016-08-10 |
| 2016-03-31 | $2.66M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $1.91M 10-K · filed 2017-02-23 |
| 2015-09-30 | $1.00M 10-Q · filed 2015-11-12 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |